PUNTA GORDA, Florida–Florida is scheduled to receive 4,000 doses of a monoclonal antibody treatment that the U.S. Food and Drug Administration (FDA) has found to be effective against the omicron variant that is derived from COVID-19. On Feb. 11, the FDA sent a letter to Eli Lily, the maker of Bebtelovimab, that the company has its approval for an Emergency Use Authorization (EUA) to treat mild to moderate COVID-19 in adults and pediatric patients, age 12 years and up. The Florida Department of Health met with Health and Human Services (HHS) on Feb. 15, to discuss the number of doses that Florida would receive and, so far, that number is 4,000. Of the total 600,000 doses initially ordered by HHS, no one on the federal or state level will confirm whether these doses have been shipped or received. The same schedule for distribution is expected to be in effect as … » Read full article
UK Leading the Way Back to Sanity? “UK Supreme Court rules trans women are not real women”
https://x.com/OzraeliAvi/status/1912663931547680785 Watch the electric response in a packed courtroom of women as the UK Supreme Court delivers a landmark ruling, defining “woman” under the law as exclusively those born
